The Invisible Cost Of Antibiotics On Vaccine Efficacy

Antimicrobial resistance (AMR) has rightly dominated global discussions on antibiotic use in animal agriculture.. However, another important but less visible consequence is emerging—the impact of antibiotics on vaccine efficacy. While antibiotics  remain essential tools for controlling bacterial infections, their broader biological effects—particularly on the gut microbiome—can significantly influence how animals respond to vaccination. This interaction introduces a hidden cost that affects health outcomes, production efficiency, and the overall return on investment in vaccination programs.

Training the Immune System: Lessons from the Gut

The gut microbiome plays a central role in shaping immune competence. The gastrointestinal tract is home to a highly complex and dynamic microbial ecosystem and, in chickens, may contain 10¹² colony-forming units per gram. This community of commensal bacteria is not passive—it actively communicates with the host immune system through a continuous exchange of molecular signals. These signals regulate immune development, calibrate inflammatory responses, and prime the system to respond effectively to pathogens and vaccines.

From early life, microbial colonization helps train both innate immunity, which provides rapid  but non-specific protection without creating  long-term immune memory. and adaptive immunity, which creates memory cells so that if the same pathogen returns, the immune  response is much faster and stronger. This  is the basic principle behind how vaccines work.

The gut microbiome also produces beneficial compounds that strengthen immunity and protect the gut. For example, short-chain fatty acids (SCFAs), produced through microbial fermentation of dietary fibers, are known to enhance antibody production and support the differentiation of memory T cells. Without these metabolites, the immune system may struggle to generate long-lasting protection following vaccination.

When antibiotics are used, particularly broad-spectrum antibiotics, this finely tuned system is disrupted. Antibiotics do not discriminate between pathogenic and beneficial bacteria, often leading to a significant reduction in microbial diversity and abundance,  both of which are widely used as indicators of gut health. This condition, known as dysbiosis, alters both the composition and functionality of the gut microbiota. As a result, the signaling pathways that support immune education and responsiveness are diminished.

Dysbiosis and the Hidden Cost to Vaccines

This disruption has direct consequences for vaccination. Vaccines rely on a competent immune system to recognize antigens, activate immune cells, and generate both humoral responses, in which  the body makes antibodies against the vaccine antigen and cell-mediated responses, where specific T cells are activated to find and destroy infected cells, release cytokines, and help coordinate other immune cells to clear the infection. In a dysbiotic gut environment, the immune system may be inadequately primed, leading to suboptimal vaccine responses. Reduced microbial-derived immune stimulation means that antigen-presenting cells, such as dendritic cells, may be less effective in initiating immune activation. Consequently, B-cell and T-cell responses are often weaker and less consistent.

Effect of antibiotics on gut microbiome and immune competence

From Poultry to People—Microbiome Impacts on Vaccines

Evidence  shows that antibiotic-induced depletion of gut microbiota can significantly impair responses to vaccines. Examples include the following:

Poultry

• Mixing antibiotics with an inactivated oil-in-water adjuvant avian influenza vaccine and administrating them as one shot demonstrated a 36% reduction in hemagglutination inhibition (HI) titers against the H9 strain in groups receiving the vaccine combined with antibiotics (El-Boraey et al., 2024).

• Responses to vaccines for Infectious Bursal Disease, Newcastle Disease Virus, Infection Bronchitis Virus, Encephalomyelitis Virus, and Avian Metapneumovirus in laying hens are  influenced by the combined effects of genetics, microbiota  and rearing conditions (Racanati et al., 2024).

Pigs

• Numerous studies proved that doxycycline use can adversely affect immune response in pigs (Augustyniak and Pomorska-Mól^, 2023).

• Simultaneous vaccination, both live and inactivated, against pseudorabies (PRV) together with treatment using enrofloxacin may alter the immune response to the vaccine. The administration of therapeutic doses of enrofloxacin reduced both the humoral and cellular post-vaccinal immune response against PRV (Pomorska-Mól et al., 2015).

Humans

• The literature provides strong evidence that the gut microbiota, particularly the bacterial component, can influence responses to vaccination in humans, with varying effects depending on the vaccine technology platform, antigen, age of the individual, and route of administration (Rossouw et al., 2024).

Disrupted Microbiota, Disappointing Vaccine Outcomes

Animals with disrupted or less diverse gut microbiota are more likely to become “low responders,” even when vaccines are properly. The mechanisms underlying these effects are multifaceted. First, dysbiosis can impair the development and function of gut-associated lymphoid tissue (GALT), which plays a crucial role in mucosal immunity. Second, reduced microbial diversity can weaken the integrity of the intestinal barrier, increasing permeability and allowing translocation of bacterial components that trigger chronic low-grade inflammation. This persistent inflammatory state can divert immune resources and reduce the efficiency of vaccine-induced responses.

From a production perspective, the implications are significant. Vaccination programs are a cornerstone of disease prevention in modern animal agriculture and represent a substantial investment in both time and resources. When vaccine efficacy is compromised, the expected level of protection may not be achieved, leading to increased disease incidence, slower recovery rates, and greater variability in performance across flocks or herds.

Producers may observe that, despite correct vaccine storage, handling, and administration, disease outbreaks still occur or clinical signs persist. In such cases, the underlying issue may not be the vaccine itself, but rather the physiological state of the animal—specifically, the condition of the gut microbiome. This disconnect can lead to misinterpretation of vaccine performance and, in some cases, unnecessary adjustments to vaccination protocols rather than addressing the root cause.

The Vicious Cycle—Dysbiosis, Disease Pressure and Antibiotic Treatment

Reliance on antibiotics to manage these issues can create a reinforcing cycle in which microbiome disruption leads to weaker immunity, increased disease pressure, and further antibiotic use.

This dynamic underscores the importance of integrating microbiome preservation into broader health management strategies. Within the One Health framework, maintaining a balanced gut microbiome is not only beneficial for animal health, but also contributes to reducing antimicrobial use and mitigating the risk of AMR development.

Biosecurity and Hygiene as the First Line of Defense

The most effective disease prevention strategy remains prevention itself. By reducing infection pressure through robust biosecurity and hygiene measures, the need for antibiotic intervention can be minimized. This includes controlling pathogen entry, maintaining clean housing conditions, managing stocking densities, and ensuring proper ventilation. Vaccination  remains a critical tool, but its success depends on the readiness of the immune system to respond—something that is deeply influenced by the gut microbiome.

As the industry continues to move toward more sustainable and responsible production systems, the role of the microbiome is gaining increasing recognition. It is no longer sufficient to view antibiotics solely through the lens of resistance. Their broader biological effects must also be considered, particularly in relation to immune function and vaccine performance.

Understanding this connection allows producers, veterinarians, and nutritionists to make more informed decisions that optimize both health and productivity. By protecting the gut microbiome, it is possible to enhance vaccine efficacy, reduce disease risk, and improve overall system resilience.

Want To Know More?

This technical article is part of Ecolex Animal Nutrition’s continuing knowledge transfer efforts, supporting more sustainable and resilient animal production systems.

Follow us at www.ecolex.com as the company shares more actionable One Health insights and strategies for building a more secure, resilient food system from farm to fork.

References available on request.